(Q37993918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author

Parish P. Sedghizadeh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

S Patel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

S Choyee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J Uyanne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A L Nguyen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

P Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J Lytle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

S Shi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A D Le

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

1 reference

15 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

625-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420684%20AND%20SRC:MED&resulttype=core&format=json

The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Imaging findings in bisphosphonate-related osteonecrosis of jaws

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Osteonecrosis of the Jaw After Zoledronic Acid and Denosumab Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Radiographic Findings in Bisphosphonate-Treated Patients With Stage 0 Disease in the Absence of Bone Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Bisphosphonate complications including osteonecrosis of the jaw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Bisphosphonate‐related osteonecrosis of the jaw: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Osteonecrosis of the jaws and bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2012.01911.X